nodes	percent_of_prediction	percent_of_DWPC	metapath
Arformoterol—CYP2A6—Fluorouracil—colon cancer	0.298	0.52	CbGbCtD
Arformoterol—CYP2C9—Capecitabine—colon cancer	0.173	0.301	CbGbCtD
Arformoterol—CYP2C9—Fluorouracil—colon cancer	0.102	0.179	CbGbCtD
Arformoterol—Musculoskeletal stiffness—Methotrexate—colon cancer	0.00174	0.00407	CcSEcCtD
Arformoterol—Skin discolouration—Methotrexate—colon cancer	0.00173	0.00404	CcSEcCtD
Arformoterol—Bone disorder—Methotrexate—colon cancer	0.00173	0.00404	CcSEcCtD
Arformoterol—Acute coronary syndrome—Irinotecan—colon cancer	0.00173	0.00404	CcSEcCtD
Arformoterol—Myocardial infarction—Irinotecan—colon cancer	0.00172	0.00402	CcSEcCtD
Arformoterol—Gastroenteritis—Capecitabine—colon cancer	0.00172	0.00402	CcSEcCtD
Arformoterol—Herpes simplex—Methotrexate—colon cancer	0.00169	0.00396	CcSEcCtD
Arformoterol—Acute coronary syndrome—Fluorouracil—colon cancer	0.00165	0.00387	CcSEcCtD
Arformoterol—Myocardial infarction—Fluorouracil—colon cancer	0.00164	0.00385	CcSEcCtD
Arformoterol—Urinary tract infection—Fluorouracil—colon cancer	0.00163	0.00382	CcSEcCtD
Arformoterol—Conjunctivitis—Fluorouracil—colon cancer	0.00163	0.00382	CcSEcCtD
Arformoterol—Inflammation—Methotrexate—colon cancer	0.00161	0.00377	CcSEcCtD
Arformoterol—Atrial fibrillation—Capecitabine—colon cancer	0.00161	0.00376	CcSEcCtD
Arformoterol—Urinary tract disorder—Vincristine—colon cancer	0.00159	0.00373	CcSEcCtD
Arformoterol—Connective tissue disorder—Vincristine—colon cancer	0.00159	0.00371	CcSEcCtD
Arformoterol—Urethral disorder—Vincristine—colon cancer	0.00158	0.00371	CcSEcCtD
Arformoterol—Rhinitis—Irinotecan—colon cancer	0.00158	0.00369	CcSEcCtD
Arformoterol—Sinusitis—Fluorouracil—colon cancer	0.00157	0.00368	CcSEcCtD
Arformoterol—Arthritis—Capecitabine—colon cancer	0.00157	0.00366	CcSEcCtD
Arformoterol—Connective tissue disorder—Irinotecan—colon cancer	0.00155	0.00362	CcSEcCtD
Arformoterol—Cystitis noninfective—Methotrexate—colon cancer	0.00152	0.00357	CcSEcCtD
Arformoterol—Melaena—Methotrexate—colon cancer	0.00152	0.00357	CcSEcCtD
Arformoterol—Visual impairment—Irinotecan—colon cancer	0.00152	0.00355	CcSEcCtD
Arformoterol—Rhinitis—Fluorouracil—colon cancer	0.00151	0.00353	CcSEcCtD
Arformoterol—Cystitis—Methotrexate—colon cancer	0.00151	0.00353	CcSEcCtD
Arformoterol—Cardiac disorder—Vincristine—colon cancer	0.0015	0.00351	CcSEcCtD
Arformoterol—Pharyngitis—Fluorouracil—colon cancer	0.00149	0.0035	CcSEcCtD
Arformoterol—Cardiac disorder—Irinotecan—colon cancer	0.00146	0.00342	CcSEcCtD
Arformoterol—Mediastinal disorder—Vincristine—colon cancer	0.00146	0.00341	CcSEcCtD
Arformoterol—Immune system disorder—Irinotecan—colon cancer	0.00142	0.00333	CcSEcCtD
Arformoterol—Mediastinal disorder—Irinotecan—colon cancer	0.00142	0.00332	CcSEcCtD
Arformoterol—Dehydration—Capecitabine—colon cancer	0.00141	0.00331	CcSEcCtD
Arformoterol—Mental disorder—Vincristine—colon cancer	0.00141	0.00331	CcSEcCtD
Arformoterol—Neoplasm—Methotrexate—colon cancer	0.00141	0.0033	CcSEcCtD
Arformoterol—Bladder pain—Methotrexate—colon cancer	0.00141	0.0033	CcSEcCtD
Arformoterol—Arrhythmia—Irinotecan—colon cancer	0.0014	0.00329	CcSEcCtD
Arformoterol—Dry skin—Capecitabine—colon cancer	0.00139	0.00326	CcSEcCtD
Arformoterol—Hypokalaemia—Capecitabine—colon cancer	0.00138	0.00324	CcSEcCtD
Arformoterol—Nasopharyngitis—Capecitabine—colon cancer	0.00136	0.00318	CcSEcCtD
Arformoterol—Back pain—Vincristine—colon cancer	0.00136	0.00318	CcSEcCtD
Arformoterol—Gastritis—Capecitabine—colon cancer	0.00135	0.00315	CcSEcCtD
Arformoterol—Arrhythmia—Fluorouracil—colon cancer	0.00135	0.00315	CcSEcCtD
Arformoterol—Back pain—Irinotecan—colon cancer	0.00132	0.0031	CcSEcCtD
Arformoterol—Muscle spasms—Irinotecan—colon cancer	0.00132	0.00308	CcSEcCtD
Arformoterol—Influenza—Capecitabine—colon cancer	0.00131	0.00308	CcSEcCtD
Arformoterol—Asthma—Capecitabine—colon cancer	0.00131	0.00308	CcSEcCtD
Arformoterol—Bronchospasm—Capecitabine—colon cancer	0.00129	0.00303	CcSEcCtD
Arformoterol—Agitation—Vincristine—colon cancer	0.00129	0.00302	CcSEcCtD
Arformoterol—Angina pectoris—Capecitabine—colon cancer	0.00128	0.003	CcSEcCtD
Arformoterol—Ill-defined disorder—Irinotecan—colon cancer	0.00127	0.00297	CcSEcCtD
Arformoterol—Bronchitis—Capecitabine—colon cancer	0.00126	0.00296	CcSEcCtD
Arformoterol—Malaise—Irinotecan—colon cancer	0.00123	0.00289	CcSEcCtD
Arformoterol—Upper respiratory tract infection—Capecitabine—colon cancer	0.00122	0.00286	CcSEcCtD
Arformoterol—Hypertension—Vincristine—colon cancer	0.00121	0.00284	CcSEcCtD
Arformoterol—Myalgia—Vincristine—colon cancer	0.0012	0.0028	CcSEcCtD
Arformoterol—Cough—Irinotecan—colon cancer	0.00119	0.0028	CcSEcCtD
Arformoterol—Hyperglycaemia—Capecitabine—colon cancer	0.00119	0.00278	CcSEcCtD
Arformoterol—Hypertension—Irinotecan—colon cancer	0.00118	0.00277	CcSEcCtD
Arformoterol—Acute coronary syndrome—Capecitabine—colon cancer	0.00116	0.00271	CcSEcCtD
Arformoterol—Discomfort—Irinotecan—colon cancer	0.00115	0.0027	CcSEcCtD
Arformoterol—Myocardial infarction—Capecitabine—colon cancer	0.00115	0.00269	CcSEcCtD
Arformoterol—Oedema—Vincristine—colon cancer	0.00115	0.00269	CcSEcCtD
Arformoterol—Anaphylactic shock—Vincristine—colon cancer	0.00115	0.00269	CcSEcCtD
Arformoterol—Infection—Vincristine—colon cancer	0.00114	0.00267	CcSEcCtD
Arformoterol—Urinary tract infection—Capecitabine—colon cancer	0.00114	0.00267	CcSEcCtD
Arformoterol—Conjunctivitis—Capecitabine—colon cancer	0.00114	0.00267	CcSEcCtD
Arformoterol—Nervous system disorder—Vincristine—colon cancer	0.00112	0.00263	CcSEcCtD
Arformoterol—Haematuria—Capecitabine—colon cancer	0.00112	0.00262	CcSEcCtD
Arformoterol—Anaphylactic shock—Irinotecan—colon cancer	0.00112	0.00262	CcSEcCtD
Arformoterol—Oedema—Irinotecan—colon cancer	0.00112	0.00262	CcSEcCtD
Arformoterol—Myalgia—Fluorouracil—colon cancer	0.00112	0.00261	CcSEcCtD
Arformoterol—Chest pain—Fluorouracil—colon cancer	0.00112	0.00261	CcSEcCtD
Arformoterol—Infection—Irinotecan—colon cancer	0.00111	0.0026	CcSEcCtD
Arformoterol—Discomfort—Fluorouracil—colon cancer	0.0011	0.00258	CcSEcCtD
Arformoterol—Nervous system disorder—Irinotecan—colon cancer	0.0011	0.00257	CcSEcCtD
Arformoterol—Hypotension—Vincristine—colon cancer	0.00107	0.00251	CcSEcCtD
Arformoterol—Anaphylactic shock—Fluorouracil—colon cancer	0.00107	0.00251	CcSEcCtD
Arformoterol—Oedema—Fluorouracil—colon cancer	0.00107	0.00251	CcSEcCtD
Arformoterol—Infection—Fluorouracil—colon cancer	0.00106	0.00249	CcSEcCtD
Arformoterol—Rhinitis—Capecitabine—colon cancer	0.00105	0.00247	CcSEcCtD
Arformoterol—Nervous system disorder—Fluorouracil—colon cancer	0.00105	0.00246	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Vincristine—colon cancer	0.00105	0.00245	CcSEcCtD
Arformoterol—Pharyngitis—Capecitabine—colon cancer	0.00104	0.00245	CcSEcCtD
Arformoterol—Tachycardia—Fluorouracil—colon cancer	0.00104	0.00244	CcSEcCtD
Arformoterol—Hypotension—Irinotecan—colon cancer	0.00104	0.00244	CcSEcCtD
Arformoterol—Urinary tract disorder—Capecitabine—colon cancer	0.00104	0.00243	CcSEcCtD
Arformoterol—Insomnia—Vincristine—colon cancer	0.00104	0.00243	CcSEcCtD
Arformoterol—Oedema peripheral—Capecitabine—colon cancer	0.00104	0.00243	CcSEcCtD
Arformoterol—Connective tissue disorder—Capecitabine—colon cancer	0.00103	0.00242	CcSEcCtD
Arformoterol—Urethral disorder—Capecitabine—colon cancer	0.00103	0.00242	CcSEcCtD
Arformoterol—Visual impairment—Capecitabine—colon cancer	0.00101	0.00237	CcSEcCtD
Arformoterol—Insomnia—Irinotecan—colon cancer	0.00101	0.00237	CcSEcCtD
Arformoterol—Hypotension—Fluorouracil—colon cancer	0.001	0.00234	CcSEcCtD
Arformoterol—Dyspnoea—Irinotecan—colon cancer	0.000996	0.00233	CcSEcCtD
Arformoterol—Somnolence—Irinotecan—colon cancer	0.000993	0.00233	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Vincristine—colon cancer	0.00099	0.00232	CcSEcCtD
Arformoterol—Fatigue—Vincristine—colon cancer	0.000989	0.00232	CcSEcCtD
Arformoterol—Dyspepsia—Irinotecan—colon cancer	0.000983	0.0023	CcSEcCtD
Arformoterol—Constipation—Vincristine—colon cancer	0.000981	0.0023	CcSEcCtD
Arformoterol—Pain—Vincristine—colon cancer	0.000981	0.0023	CcSEcCtD
Arformoterol—Asthma—Methotrexate—colon cancer	0.000979	0.00229	CcSEcCtD
Arformoterol—Cardiac disorder—Capecitabine—colon cancer	0.000977	0.00229	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000975	0.00228	CcSEcCtD
Arformoterol—Insomnia—Fluorouracil—colon cancer	0.000968	0.00227	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Irinotecan—colon cancer	0.000964	0.00226	CcSEcCtD
Arformoterol—Fatigue—Irinotecan—colon cancer	0.000963	0.00226	CcSEcCtD
Arformoterol—Pain—Irinotecan—colon cancer	0.000955	0.00224	CcSEcCtD
Arformoterol—Constipation—Irinotecan—colon cancer	0.000955	0.00224	CcSEcCtD
Arformoterol—Dyspnoea—Fluorouracil—colon cancer	0.000954	0.00223	CcSEcCtD
Arformoterol—Somnolence—Fluorouracil—colon cancer	0.000951	0.00223	CcSEcCtD
Arformoterol—Immune system disorder—Capecitabine—colon cancer	0.00095	0.00223	CcSEcCtD
Arformoterol—Mediastinal disorder—Capecitabine—colon cancer	0.000948	0.00222	CcSEcCtD
Arformoterol—Dyspepsia—Fluorouracil—colon cancer	0.000942	0.00221	CcSEcCtD
Arformoterol—Arrhythmia—Capecitabine—colon cancer	0.00094	0.0022	CcSEcCtD
Arformoterol—Gastrointestinal pain—Vincristine—colon cancer	0.000938	0.0022	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000924	0.00216	CcSEcCtD
Arformoterol—Mental disorder—Capecitabine—colon cancer	0.000922	0.00216	CcSEcCtD
Arformoterol—Feeling abnormal—Irinotecan—colon cancer	0.00092	0.00216	CcSEcCtD
Arformoterol—Malnutrition—Capecitabine—colon cancer	0.000916	0.00214	CcSEcCtD
Arformoterol—Pain—Fluorouracil—colon cancer	0.000915	0.00214	CcSEcCtD
Arformoterol—Gastrointestinal pain—Irinotecan—colon cancer	0.000913	0.00214	CcSEcCtD
Arformoterol—Upper respiratory tract infection—Methotrexate—colon cancer	0.00091	0.00213	CcSEcCtD
Arformoterol—Abdominal pain—Vincristine—colon cancer	0.000907	0.00212	CcSEcCtD
Arformoterol—Body temperature increased—Vincristine—colon cancer	0.000907	0.00212	CcSEcCtD
Arformoterol—Dysgeusia—Capecitabine—colon cancer	0.000897	0.0021	CcSEcCtD
Arformoterol—Back pain—Capecitabine—colon cancer	0.000886	0.00207	CcSEcCtD
Arformoterol—Body temperature increased—Irinotecan—colon cancer	0.000883	0.00207	CcSEcCtD
Arformoterol—Abdominal pain—Irinotecan—colon cancer	0.000883	0.00207	CcSEcCtD
Arformoterol—Feeling abnormal—Fluorouracil—colon cancer	0.000882	0.00206	CcSEcCtD
Arformoterol—Muscle spasms—Capecitabine—colon cancer	0.000881	0.00206	CcSEcCtD
Arformoterol—Tremor—Capecitabine—colon cancer	0.000858	0.00201	CcSEcCtD
Arformoterol—Ill-defined disorder—Capecitabine—colon cancer	0.00085	0.00199	CcSEcCtD
Arformoterol—Urticaria—Fluorouracil—colon cancer	0.00085	0.00199	CcSEcCtD
Arformoterol—Conjunctivitis—Methotrexate—colon cancer	0.000848	0.00199	CcSEcCtD
Arformoterol—Body temperature increased—Fluorouracil—colon cancer	0.000846	0.00198	CcSEcCtD
Arformoterol—Hypersensitivity—Vincristine—colon cancer	0.000845	0.00198	CcSEcCtD
Arformoterol—Haematuria—Methotrexate—colon cancer	0.000832	0.00195	CcSEcCtD
Arformoterol—Malaise—Capecitabine—colon cancer	0.000826	0.00193	CcSEcCtD
Arformoterol—Hypersensitivity—Irinotecan—colon cancer	0.000823	0.00193	CcSEcCtD
Arformoterol—Asthenia—Vincristine—colon cancer	0.000823	0.00193	CcSEcCtD
Arformoterol—Palpitations—Capecitabine—colon cancer	0.00081	0.0019	CcSEcCtD
Arformoterol—Asthenia—Irinotecan—colon cancer	0.000801	0.00188	CcSEcCtD
Arformoterol—Cough—Capecitabine—colon cancer	0.000799	0.00187	CcSEcCtD
Arformoterol—Hypertension—Capecitabine—colon cancer	0.000791	0.00185	CcSEcCtD
Arformoterol—Hypersensitivity—Fluorouracil—colon cancer	0.000788	0.00185	CcSEcCtD
Arformoterol—Diarrhoea—Vincristine—colon cancer	0.000785	0.00184	CcSEcCtD
Arformoterol—Arthralgia—Capecitabine—colon cancer	0.00078	0.00183	CcSEcCtD
Arformoterol—Chest pain—Capecitabine—colon cancer	0.00078	0.00183	CcSEcCtD
Arformoterol—Myalgia—Capecitabine—colon cancer	0.00078	0.00183	CcSEcCtD
Arformoterol—Pharyngitis—Methotrexate—colon cancer	0.000777	0.00182	CcSEcCtD
Arformoterol—Anxiety—Capecitabine—colon cancer	0.000777	0.00182	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000775	0.00181	CcSEcCtD
Arformoterol—Urinary tract disorder—Methotrexate—colon cancer	0.000774	0.00181	CcSEcCtD
Arformoterol—Discomfort—Capecitabine—colon cancer	0.000771	0.0018	CcSEcCtD
Arformoterol—Urethral disorder—Methotrexate—colon cancer	0.000768	0.0018	CcSEcCtD
Arformoterol—Diarrhoea—Irinotecan—colon cancer	0.000764	0.00179	CcSEcCtD
Arformoterol—Dry mouth—Capecitabine—colon cancer	0.000763	0.00179	CcSEcCtD
Arformoterol—Dizziness—Vincristine—colon cancer	0.000758	0.00178	CcSEcCtD
Arformoterol—Pruritus—Fluorouracil—colon cancer	0.000757	0.00177	CcSEcCtD
Arformoterol—Visual impairment—Methotrexate—colon cancer	0.000755	0.00177	CcSEcCtD
Arformoterol—Oedema—Capecitabine—colon cancer	0.000748	0.00175	CcSEcCtD
Arformoterol—Infection—Capecitabine—colon cancer	0.000743	0.00174	CcSEcCtD
Arformoterol—Dizziness—Irinotecan—colon cancer	0.000739	0.00173	CcSEcCtD
Arformoterol—Nervous system disorder—Capecitabine—colon cancer	0.000733	0.00172	CcSEcCtD
Arformoterol—Diarrhoea—Fluorouracil—colon cancer	0.000732	0.00171	CcSEcCtD
Arformoterol—Tachycardia—Capecitabine—colon cancer	0.00073	0.00171	CcSEcCtD
Arformoterol—Vomiting—Vincristine—colon cancer	0.000729	0.00171	CcSEcCtD
Arformoterol—Cardiac disorder—Methotrexate—colon cancer	0.000727	0.0017	CcSEcCtD
Arformoterol—Skin disorder—Capecitabine—colon cancer	0.000726	0.0017	CcSEcCtD
Arformoterol—Rash—Vincristine—colon cancer	0.000723	0.00169	CcSEcCtD
Arformoterol—Dermatitis—Vincristine—colon cancer	0.000723	0.00169	CcSEcCtD
Arformoterol—Headache—Vincristine—colon cancer	0.000719	0.00168	CcSEcCtD
Arformoterol—Vomiting—Irinotecan—colon cancer	0.00071	0.00166	CcSEcCtD
Arformoterol—Immune system disorder—Methotrexate—colon cancer	0.000708	0.00166	CcSEcCtD
Arformoterol—Dizziness—Fluorouracil—colon cancer	0.000707	0.00166	CcSEcCtD
Arformoterol—Mediastinal disorder—Methotrexate—colon cancer	0.000706	0.00165	CcSEcCtD
Arformoterol—Rash—Irinotecan—colon cancer	0.000704	0.00165	CcSEcCtD
Arformoterol—Dermatitis—Irinotecan—colon cancer	0.000704	0.00165	CcSEcCtD
Arformoterol—Headache—Irinotecan—colon cancer	0.0007	0.00164	CcSEcCtD
Arformoterol—Hypotension—Capecitabine—colon cancer	0.000699	0.00164	CcSEcCtD
Arformoterol—Mental disorder—Methotrexate—colon cancer	0.000686	0.00161	CcSEcCtD
Arformoterol—Malnutrition—Methotrexate—colon cancer	0.000682	0.0016	CcSEcCtD
Arformoterol—Nausea—Vincristine—colon cancer	0.000681	0.0016	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000681	0.00159	CcSEcCtD
Arformoterol—Vomiting—Fluorouracil—colon cancer	0.00068	0.00159	CcSEcCtD
Arformoterol—Insomnia—Capecitabine—colon cancer	0.000676	0.00158	CcSEcCtD
Arformoterol—Rash—Fluorouracil—colon cancer	0.000675	0.00158	CcSEcCtD
Arformoterol—Dermatitis—Fluorouracil—colon cancer	0.000674	0.00158	CcSEcCtD
Arformoterol—Headache—Fluorouracil—colon cancer	0.00067	0.00157	CcSEcCtD
Arformoterol—Dysgeusia—Methotrexate—colon cancer	0.000668	0.00156	CcSEcCtD
Arformoterol—Dyspnoea—Capecitabine—colon cancer	0.000667	0.00156	CcSEcCtD
Arformoterol—Nausea—Irinotecan—colon cancer	0.000664	0.00155	CcSEcCtD
Arformoterol—Back pain—Methotrexate—colon cancer	0.00066	0.00154	CcSEcCtD
Arformoterol—Dyspepsia—Capecitabine—colon cancer	0.000658	0.00154	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Capecitabine—colon cancer	0.000645	0.00151	CcSEcCtD
Arformoterol—Fatigue—Capecitabine—colon cancer	0.000645	0.00151	CcSEcCtD
Arformoterol—Pain—Capecitabine—colon cancer	0.000639	0.0015	CcSEcCtD
Arformoterol—Constipation—Capecitabine—colon cancer	0.000639	0.0015	CcSEcCtD
Arformoterol—Nausea—Fluorouracil—colon cancer	0.000635	0.00149	CcSEcCtD
Arformoterol—Ill-defined disorder—Methotrexate—colon cancer	0.000633	0.00148	CcSEcCtD
Arformoterol—Feeling abnormal—Capecitabine—colon cancer	0.000616	0.00144	CcSEcCtD
Arformoterol—Malaise—Methotrexate—colon cancer	0.000615	0.00144	CcSEcCtD
Arformoterol—Gastrointestinal pain—Capecitabine—colon cancer	0.000611	0.00143	CcSEcCtD
Arformoterol—Cough—Methotrexate—colon cancer	0.000595	0.00139	CcSEcCtD
Arformoterol—Urticaria—Capecitabine—colon cancer	0.000594	0.00139	CcSEcCtD
Arformoterol—Abdominal pain—Capecitabine—colon cancer	0.000591	0.00138	CcSEcCtD
Arformoterol—Body temperature increased—Capecitabine—colon cancer	0.000591	0.00138	CcSEcCtD
Arformoterol—Myalgia—Methotrexate—colon cancer	0.000581	0.00136	CcSEcCtD
Arformoterol—Arthralgia—Methotrexate—colon cancer	0.000581	0.00136	CcSEcCtD
Arformoterol—Chest pain—Methotrexate—colon cancer	0.000581	0.00136	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000577	0.00135	CcSEcCtD
Arformoterol—Discomfort—Methotrexate—colon cancer	0.000574	0.00134	CcSEcCtD
Arformoterol—Anaphylactic shock—Methotrexate—colon cancer	0.000557	0.0013	CcSEcCtD
Arformoterol—Infection—Methotrexate—colon cancer	0.000553	0.00129	CcSEcCtD
Arformoterol—Hypersensitivity—Capecitabine—colon cancer	0.000551	0.00129	CcSEcCtD
Arformoterol—Nervous system disorder—Methotrexate—colon cancer	0.000546	0.00128	CcSEcCtD
Arformoterol—Skin disorder—Methotrexate—colon cancer	0.000541	0.00127	CcSEcCtD
Arformoterol—Asthenia—Capecitabine—colon cancer	0.000536	0.00126	CcSEcCtD
Arformoterol—Pruritus—Capecitabine—colon cancer	0.000529	0.00124	CcSEcCtD
Arformoterol—Hypotension—Methotrexate—colon cancer	0.00052	0.00122	CcSEcCtD
Arformoterol—Diarrhoea—Capecitabine—colon cancer	0.000512	0.0012	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000507	0.00119	CcSEcCtD
Arformoterol—Insomnia—Methotrexate—colon cancer	0.000503	0.00118	CcSEcCtD
Arformoterol—Dyspnoea—Methotrexate—colon cancer	0.000496	0.00116	CcSEcCtD
Arformoterol—Somnolence—Methotrexate—colon cancer	0.000495	0.00116	CcSEcCtD
Arformoterol—Dizziness—Capecitabine—colon cancer	0.000494	0.00116	CcSEcCtD
Arformoterol—Dyspepsia—Methotrexate—colon cancer	0.00049	0.00115	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Methotrexate—colon cancer	0.00048	0.00113	CcSEcCtD
Arformoterol—Fatigue—Methotrexate—colon cancer	0.00048	0.00112	CcSEcCtD
Arformoterol—Pain—Methotrexate—colon cancer	0.000476	0.00111	CcSEcCtD
Arformoterol—Vomiting—Capecitabine—colon cancer	0.000475	0.00111	CcSEcCtD
Arformoterol—Rash—Capecitabine—colon cancer	0.000471	0.0011	CcSEcCtD
Arformoterol—Dermatitis—Capecitabine—colon cancer	0.000471	0.0011	CcSEcCtD
Arformoterol—Headache—Capecitabine—colon cancer	0.000468	0.0011	CcSEcCtD
Arformoterol—Feeling abnormal—Methotrexate—colon cancer	0.000459	0.00107	CcSEcCtD
Arformoterol—Gastrointestinal pain—Methotrexate—colon cancer	0.000455	0.00107	CcSEcCtD
Arformoterol—Nausea—Capecitabine—colon cancer	0.000444	0.00104	CcSEcCtD
Arformoterol—Urticaria—Methotrexate—colon cancer	0.000442	0.00104	CcSEcCtD
Arformoterol—Abdominal pain—Methotrexate—colon cancer	0.00044	0.00103	CcSEcCtD
Arformoterol—Body temperature increased—Methotrexate—colon cancer	0.00044	0.00103	CcSEcCtD
Arformoterol—Hypersensitivity—Methotrexate—colon cancer	0.00041	0.00096	CcSEcCtD
Arformoterol—Asthenia—Methotrexate—colon cancer	0.000399	0.000935	CcSEcCtD
Arformoterol—Pruritus—Methotrexate—colon cancer	0.000394	0.000922	CcSEcCtD
Arformoterol—Diarrhoea—Methotrexate—colon cancer	0.000381	0.000892	CcSEcCtD
Arformoterol—Dizziness—Methotrexate—colon cancer	0.000368	0.000862	CcSEcCtD
Arformoterol—Vomiting—Methotrexate—colon cancer	0.000354	0.000829	CcSEcCtD
Arformoterol—Rash—Methotrexate—colon cancer	0.000351	0.000822	CcSEcCtD
Arformoterol—Dermatitis—Methotrexate—colon cancer	0.000351	0.000821	CcSEcCtD
Arformoterol—Headache—Methotrexate—colon cancer	0.000349	0.000816	CcSEcCtD
Arformoterol—Nausea—Methotrexate—colon cancer	0.000331	0.000774	CcSEcCtD
